Prime Therapeutics Completes $1.35B Deal to Acquire Magellan Rx

December 5, 2022

Managed Healthcare Executive

Related news

In the news

December 19, 2022

How to Ascend in Your Career (With Erin Feigal)

People Make it Possible podcast

In the news

December 16, 2022

Prime Therapeutics joins other PBMs in adding Humira biosimilars

Becker’s Payer Issues